Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geldenhuys

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|November 8, 2021
Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a <i>C. elegans</i> model of Parkinson's diseaseJacob Boos, Ahmed Shubbar, Werner J Geldenhuys
International Journal of Pharmaceutics|February 1, 2020
Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injuryPushkar Saralkar, Tasneem Arsiwala, Werner J Geldenhuys
Medical Hypotheses|September 12, 2006
Triquinane-based compounds as possible serotonin 5-HT(6) receptor antagonists for the treatment of Alzheimer's diseaseWerner J Geldenhuys, Cornelis J Van der Schyf
International Review of Neurobiology|October 6, 2011
Multimodal drugs and their future for Alzheimer's and Parkinson's diseaseCornelis J Van der Schyf, Werner J Geldenhuys
The Journal of Biological Chemistry|February 7, 2020
A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2)Zachary Hartman, Werner J Geldenhuys, Yehenew M Agazie
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screeningWerner J Geldenhuys, Phani K Talasila, Prabodh Sadana
Advances in Pharmacology (San Diego, Calif.)|May 26, 2023
Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular responseMohammed A Nayeem, Werner J Geldenhuys, Ahmad Hanif
Current Topics in Medicinal Chemistry|August 12, 2008
Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's diseaseWerner J Geldenhuys, Cornelis J Van der Schyf
Current Medicinal Chemistry|February 16, 2013
Rationally designed multi-targeted agents against neurodegenerative diseasesW J Geldenhuys, C J Van der Schyf
The Journal of Organic Chemistry|August 25, 2020
Synthesis of Illudinine from Dimedone and Identification of Activity as a Monoamine Oxidase InhibitorRobert Gaston, Werner J Geldenhuys, Gregory B Dudley
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|November 8, 2021
Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a <i>C. elegans</i> model of Parkinson's diseaseJacob Boos, Ahmed Shubbar, Werner J Geldenhuys
International Journal of Pharmaceutics|February 1, 2020
Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injuryPushkar Saralkar, Tasneem Arsiwala, Werner J Geldenhuys
Medical Hypotheses|September 12, 2006
Triquinane-based compounds as possible serotonin 5-HT(6) receptor antagonists for the treatment of Alzheimer's diseaseWerner J Geldenhuys, Cornelis J Van der Schyf
International Review of Neurobiology|October 6, 2011
Multimodal drugs and their future for Alzheimer's and Parkinson's diseaseCornelis J Van der Schyf, Werner J Geldenhuys
The Journal of Biological Chemistry|February 7, 2020
A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2)Zachary Hartman, Werner J Geldenhuys, Yehenew M Agazie
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Identification of a novel serum and glucocorticoid regulated kinase-1 (SGK1) ligand from virtual screeningWerner J Geldenhuys, Phani K Talasila, Prabodh Sadana
Advances in Pharmacology (San Diego, Calif.)|May 26, 2023
Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular responseMohammed A Nayeem, Werner J Geldenhuys, Ahmad Hanif
Current Topics in Medicinal Chemistry|August 12, 2008
Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's diseaseWerner J Geldenhuys, Cornelis J Van der Schyf
Current Medicinal Chemistry|February 16, 2013
Rationally designed multi-targeted agents against neurodegenerative diseasesW J Geldenhuys, C J Van der Schyf
The Journal of Organic Chemistry|August 25, 2020
Synthesis of Illudinine from Dimedone and Identification of Activity as a Monoamine Oxidase InhibitorRobert Gaston, Werner J Geldenhuys, Gregory B Dudley
Pageof 18